What is the current valuation of the US outdoor performance-apparel market?

The market valuation was $4500.0 Million in 2024. Read More

What is the projected market size for the US outdoor performance-apparel market by 2035?

The projected valuation for 2035 is $8500.0 Million. Read More

What is the expected CAGR for the US outdoor performance-apparel market during the forecast period 2025 - 2035?

The expected CAGR is 5.95% during the forecast period. Read More

Which product type segment has the highest valuation in the US outdoor performance-apparel market?

The 'Others' segment, which includes various products, had a valuation ranging from $1500.0 Million to $2800.0 Million. Read More

How do synthetic materials perform in the US outdoor performance-apparel market?

Synthetic materials are projected to have a valuation between $2700.0 Million and $5100.0 Million. Read More

What is the market performance of jackets and vests in the US outdoor performance-apparel market?

Jackets and vests had a valuation ranging from $900.0 Million to $1700.0 Million. Read More

Which consumer segment shows equal valuation in the US outdoor performance-apparel market?

The men and women consumer segments both show valuations between $1800.0 Million and $3400.0 Million. Read More

What distribution channel is expected to dominate the US outdoor performance-apparel market?

The store-based distribution channel is projected to have a valuation between $2700.0 Million and $5100.0 Million. Read More

What is the valuation range for boots and shoes in the US outdoor performance-apparel market?

Boots and shoes are valued between $1000.0 Million and $2000.0 Million. Read More

Which key players are leading the US outdoor performance-apparel market?

Key players include Nike, The North Face, Columbia Sportswear, and Patagonia. Read More

US Outdoor Performance Apparel Market

ID: MRFR/CG/12298-HCR

128 Pages

Tejas Chaudhary

Last Updated: April 06, 2026

US Outdoor Performance Apparel Market Size, Share, Industry Trend & Analysis Research Report By Product Type (Jackets & Vests, Pants & Trousers, Boots & Shoes, Base Layers, Compression Wear, Others), By Fabric Type (Woven, Knit), By Material (Natural, Synthetic), By End-User (Recreational, Professional), By Price Range (Economy/Mass, Premium), By Fabric Category (Running, Swimming & Water Sports, Cycling, Ski & Snow, Hunting & Fishing, Others), By Consumer (Men, Women, Children) andBy Distribution Channel (Store-based, Non-store-based)- Forecast to 2035

US Outdoor Performance Apparel Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Product Type (USD Million)
  1. 4.1.1 Jackets & Vests
  2. 4.1.2 Pants & Trousers
  3. 4.1.3 Boots & Shoes
  4. 4.1.4 Base Layers
  5. 4.1.5 Compression Wear
  6. 4.1.6 Others
2. 4.2 Pharmaceutical, BY Fabric Type (USD Million)
  1. 4.2.1 Woven
  2. 4.2.2 Knit
3. 4.3 Pharmaceutical, BY Material (USD Million)
  1. 4.3.1 Natural
  2. 4.3.2 Synthetic
4. 4.4 Pharmaceutical, BY End-User (USD Million)
  1. 4.4.1 Recreational
  2. 4.4.2 Professional
5. 4.5 Pharmaceutical, BY Price Range (USD Million)
  1. 4.5.1 Economic/Mass
  2. 4.5.2 Premium
6. 4.6 Pharmaceutical, BY Fabric Category (USD Million)
  1. 4.6.1 Running
  2. 4.6.2 Swimming & Water Sports
  3. 4.6.3 Cycling
  4. 4.6.4 Ski & Snow
  5. 4.6.5 Hunting & Fishing
  6. 4.6.6 Others
7. 4.7 Pharmaceutical, BY Consumer (USD Million)
  1. 4.7.1 Men
  2. 4.7.2 Women
  3. 4.7.3 Children
8. 4.8 Pharmaceutical, BY Distribution Channel (USD Million)
  1. 4.8.1 Store-based
  2. 4.8.2 Non-store-based
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Nike (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Adidas (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 The North Face (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Columbia Sportswear (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Patagonia (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Under Armour (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Arc'teryx (CA)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Marmot (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Mountain Hardwear (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 US MARKET ANALYSIS BY FABRIC TYPE
4. 6.4 US MARKET ANALYSIS BY MATERIAL
5. 6.5 US MARKET ANALYSIS BY END-USER
6. 6.6 US MARKET ANALYSIS BY PRICE RANGE
7. 6.7 US MARKET ANALYSIS BY FABRIC CATEGORY
8. 6.8 US MARKET ANALYSIS BY CONSUMER
9. 6.9 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
10. 6.10 KEY BUYING CRITERIA OF PHARMACEUTICAL
11. 6.11 RESEARCH PROCESS OF MRFR
12. 6.12 DRO ANALYSIS OF PHARMACEUTICAL
13. 6.13 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
14. 6.14 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
15. 6.15 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
16. 6.16 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY FABRIC TYPE, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY FABRIC TYPE, 2024 TO 2035 (USD Million)
20. 6.20 PHARMACEUTICAL, BY MATERIAL, 2024 (% SHARE)
21. 6.21 PHARMACEUTICAL, BY MATERIAL, 2024 TO 2035 (USD Million)
22. 6.22 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
23. 6.23 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
24. 6.24 PHARMACEUTICAL, BY PRICE RANGE, 2024 (% SHARE)
25. 6.25 PHARMACEUTICAL, BY PRICE RANGE, 2024 TO 2035 (USD Million)
26. 6.26 PHARMACEUTICAL, BY FABRIC CATEGORY, 2024 (% SHARE)
27. 6.27 PHARMACEUTICAL, BY FABRIC CATEGORY, 2024 TO 2035 (USD Million)
28. 6.28 PHARMACEUTICAL, BY CONSUMER, 2024 (% SHARE)
29. 6.29 PHARMACEUTICAL, BY CONSUMER, 2024 TO 2035 (USD Million)
30. 6.30 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
31. 6.31 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
32. 6.32 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY FABRIC TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY MATERIAL, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
  5. 7.2.5 BY PRICE RANGE, 2025-2035 (USD Million)
  6. 7.2.6 BY FABRIC CATEGORY, 2025-2035 (USD Million)
  7. 7.2.7 BY CONSUMER, 2025-2035 (USD Million)
  8. 7.2.8 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Product Type (USD Million, 2025-2035)

Jackets & Vests
Pants & Trousers
Boots & Shoes
Base Layers
Compression Wear
Others

Pharmaceutical By Fabric Type (USD Million, 2025-2035)

Woven
Knit

Pharmaceutical By Material (USD Million, 2025-2035)

Natural
Synthetic

Pharmaceutical By End-User (USD Million, 2025-2035)

Recreational
Professional

Pharmaceutical By Price Range (USD Million, 2025-2035)

Economic/Mass
Premium

Pharmaceutical By Fabric Category (USD Million, 2025-2035)

Running
Swimming & Water Sports
Cycling
Ski & Snow
Hunting & Fishing
Others

Pharmaceutical By Consumer (USD Million, 2025-2035)

Men
Women
Children

Pharmaceutical By Distribution Channel (USD Million, 2025-2035)

Store-based
Non-store-based

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”